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Introduction
Cell division is critical for the development of multicellular or-
ganisms. This process requires the proper coupling of chromo-
some segregation with the physical division of the cytoplasm 
(cytokinesis), which ensures that each daughter cell receives 
the correct complement of chromosomes and cellular material 
(Eggert et al., 2006). It has been demonstrated that cell division 
failure can cause genetic instability, ultimately leading to can-
cer (Fujiwara et al., 2005). In mammals, cell division involves 
the constriction of a contractile ring, which pinches the mother 
cell into two daughter cells once chromosome segregation has 
occurred (Glotzer, 2001). The final separation of daughter cells 
occurs via a process referred to as abscission, in which an inter-
cellular microtubule bridge called the midbody is severed.
Septins  are  a  family  of  highly  conserved  proteins,  of 
which there are 14 members in humans (SEPT1–SEPT14; 
Weirich et al., 2008). They consist of a central conserved GTP- 
binding domain flanked by N- and C-terminal extensions of vary-
ing length and divergent sequence. Many septin family members 
undergo complex alternative splicing, making the number of 
unique septin polypeptides even greater (Hall and Russell, 2004). 
These proteins associate with each other to form ordered oligo-
meric complexes and filaments (Sirajuddin et al., 2007), which 
are thought to regulate a vast array of cellular processes, including 
membrane traffic (Beites et al., 1999), phagocytosis (Huang et al., 
2008), spermatogenesis (Ihara et al., 2005; Kissel et al., 2005), 
and dendrite branching (Tada et al., 2007; Xie et al., 2007).
Septins are also important for cell division in many dif-
ferent organisms (Hall et al., 2008b). Work in mammalian cells 
showed that injection of SEPT2 antibodies at anaphase/telophase 
impaired the completion of cytokinesis (Kinoshita et al., 1997). 
Simultaneous depletion of SEPT2, SEPT6, and SEPT7 (and 
possibly others) from HeLa cells resulted in accumulation of 
cells with multiple or fragmented nuclei (Kremer et al., 2005; 
Spiliotis et al., 2005). These studies took advantage of the ob-
servation that depletion of one septin can result in the depletion 
of other septin family members, a phenomenon that is thought 
to result from destabilizing the septin complex (Kinoshita et al., 
2002). Finally, SEPT9 depletion from HMEC and HeLa cells 
caused cytokinetic defects (Surka et al., 2002; Nagata et al., 
2003), although it was not clear whether the expression of other 
septins was affected.
S
eptins  are  a  family  of  GTP-binding  proteins  im-
plicated in mammalian cell division. Most studies   
examining  the  role  of  septins  in  this  process   
have treated the family as a whole, thus neglecting the 
possibility  that  individual  members  may  have  diverse 
functions. To address this, we individually depleted each 
septin family member expressed in HeLa cells by siRNA   
and  assayed  for  defects  in  cell  division  by  immuno-
fluorescence and time-lapse microscopy. Depletion of   
SEPT2, SEPT7, and SEPT11 causes defects in the early stages 
of cytokinesis, ultimately resulting in binucleation. In sharp 
contrast, SEPT9 is dispensable for the early stages of cell 
division, but is critical for the final separation of daugh-
ter cells. Rescue experiments indicate that SEPT9 isoforms 
containing the N-terminal region are sufficient to drive 
cytokinesis. We demonstrate that SEPT9 mediates the   
localization of the vesicle-tethering exocyst complex to   
the midbody, providing mechanistic insight into the role 
of SEPT9 during abscission.
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microtubules as reported by others (Spiliotis et al., 2005). Double 
labeling showed that SEPT9 colocalizes with each other septin 
during anaphase and telophase (Fig. S1, B–E). In addition, immuno-
precipitation analysis suggested that septin complex compo-
sition is largely unaltered upon mitotic entry (Fig. S1, F and G). 
Likewise, no obvious differences in septin complex composi-
tion were observed when immunoprecipitations were performed 
from cells enriched at the later stages of cell division (Fig. S1, 
H and I). However, we cannot rule out the possibility that subtle 
rearrangements of septin subunits or septin polymerization state 
occur during cell division.
Next, we selectively depleted each septin expressed in 
HeLa cells by siRNA (Fig. 2 A) and assayed for cytokinesis de-
fects. SEPT6 knockdown (KD) had no adverse effects (Fig. 2 C),   
although this could reflect incomplete silencing. Depletion of 
SEPT2 and SEPT11 increased the number of multinucleated 
cells to 11% and 15%, respectively, compared with 3% of cells 
transfected with control siRNA (Fig. 2 C). Treatment with SEPT7 
siRNA depleted all septins, as described previously (Kinoshita 
et al., 2002; Kremer et al., 2005; Tooley et al., 2009), and in-
creased the number of multinucleated cells to 26% (Fig. 2 C).   
Although  SEPT9  KD  also  resulted  in  an  increase  in  multi-
nucleated cells (8%), we observed a second, more prominent 
cytokinetic defect (Fig. 2, B and C). Strikingly, 23% of SEPT9 
KD cells remained joined by a microtubule bridge (midbody), 
compared with 6% of cells transfected with control siRNA.   
Expression of siRNA-resistant SEPT9 rescued these cytokinetic 
defects (see Fig. 4), which demonstrates that this phenotype is 
Recent work demonstrated that SEPT2 acts as a scaffold 
for myosin II and its kinases at the cleavage furrow, thus facili-
tating the full activation of myosin II that is required for cleav-
age furrow stability (Joo et al., 2007). SEPT7 has been shown to 
mediate the localization of CENP-E to kinetochores, which is 
important for proper chromosome segregation (Zhu et al., 2008). 
However, it is unclear whether other septin family members 
within the septin complex are also important for these processes. 
Consequently, although it is well established that the septin fam-
ily is important for mammalian cell division, it remains elusive 
whether these proteins act together to perform the same role, or 
whether they have different functions during cell division.
Results and discussion
To examine the role of individual septins in cell division, we first 
determined the expression profile of septins in HeLa cells. West-
ern blotting with our septin antibodies (which may not recognize 
all isoforms) showed that HeLa cells contain SEPT2, SEPT6, 
SEPT7, SEPT9, and SEPT11 (Fig. S1 A). We next assessed the   
distribution of these septins during cell division (Fig. 1).   
In prophase and metaphase, SEPT2 showed cortical enrichment, 
whereas the others had a more diffuse cytosolic distribution. All 
septins accumulated at the cleavage furrow during anaphase, and 
appeared at both sides of the intercellular bridge and the midbody 
in telophase. Although our SEPT6 antibody had high background 
staining, it showed a similar distribution to SEPT11 (unpub-
lished data). Occasionally, septins were visualized on spindle   
Figure 1.  Septin distribution during cell division. HeLa cells were stained for -tubulin (red), DNA (blue), and the indicated septin (green). Confocal   
microscopy was performed, and a single z slice is shown. Bars, 17 µm.743 SEPT9 mediates midbody abscission • Estey et al.
both daughter nuclei, thus generating a multinucleated cell and 
an enucleated cell. In a few cases, cleavage furrow regression 
was observed, as described previously (Spiliotis et al., 2005). 
Depletion of all septins with SEPT7 siRNA had the same   
effects. A similar phenotype has been observed upon depletion 
of the septin-binding protein anillin (Straight et al., 2005), rais-
ing the possibility that SEPT2 and SEPT11 may mediate anillin 
function during cytokinesis.
Despite  the  increase  in  multinucleated  cells  observed 
upon SEPT9 KD (Fig. 2 C), these cells showed no defects in 
DNA separation, cleavage furrow constriction, or midbody for-
mation (Fig. 3 C and Video 4). Instead, SEPT9-depleted cells 
exhibited dramatic defects in midbody abscission (Fig. 3 C and 
Video 5). The midbody of control KD cells abscised an average 
of 3.9 h after the onset of cytokinesis, and all of these cells suc-
cessfully completed abscission (Fig. 3 D). In contrast, only 70% 
of SEPT9 KD cells successfully abscised, with the mean abscis-
sion time being 9 h after the initiation of cytokinesis (Fig. 3 D; 
specifically caused by depletion of SEPT9 and is not the result 
of off-target effects of our siRNA. Similar defects were observed 
upon SEPT9 KD in HEK293 cells (Fig. S1, J and K), arguing 
that this is not a HeLa cell–specific phenomenon. Intriguingly, 
this late telophase arrest was not observed upon depletion of 
any other septin (Fig. 2 C). Our results suggest that although 
septins coexist in complexes, they may have distinct functions 
during cell division.
To address this, we followed septin-depleted cells through 
cell division by time-lapse microscopy. Separation of the DNA, 
ingression of the cleavage furrow, and formation of the midbody 
appeared normal upon control KD (Fig. 3 A and Video 1). How-
ever, SEPT2 (Video 2)- and SEPT11 (Fig. 3 B and Video 3)- 
depleted cells exhibited abnormal cleavage furrow contraction 
at the early stages of cytokinesis. Although cleavage furrow in-
gression began normally, the size of the nascent daughter cells 
then fluctuated dramatically. In most cases, the cleavage furrow 
did eventually fully ingress; however, it did so to the side of 
Figure 2.  Roles of individual septins in cell division. (A) HeLa cells were treated with the indicated siRNA, and lysates were probed as specified. Numbers 
to the right of the blot represent molecular mass standards in kilodaltons. (B) Representative examples of cells treated with control siRNA, and of multinucle-
ated cells and cells attached by persistent midbodies after SEPT9 KD (red, -tubulin; blue, DNA). Bars, 17 µm. (C) Quantification of effect of septin KD on 
cytokinesis. The percentage of cells exhibiting multinucleation or midbody attachment was determined upon treatment with the indicated siRNA. Data are 
represented as mean ± SEM (error bars; n ≥ 300 cells from three or more independent experiments). Asterisks indicate differences between control and 
septin KD cells. *, P < 0.01; **, P < 0.0001.JCB • VOLUME 191 • NUMBER 4 • 2010   744
abscission. Impaired midbody abscission upon SEPT9 KD was 
also observed in noncancerous human retinal pigment epithelial 
cells (ARPE-19), which have normal karyology (Figs. 3 E and S1 L;   
Dunn et al., 1996). In these cells, SEPT9 KD increased the 
mean abscission time to 4.2 h, compared with 2.3 h for cells 
transfected with control siRNA (P < 0.01). These cells are 
highly motile, and may therefore complete abscission by me-
chanical rupture of the midbody (Steigemann and Gerlich, 
2009), which might possibly explain the faster abscission time 
and less-penetrant SEPT9 KD phenotype. Collectively, our   
P < 0.0001). Remarkably, in 20% of SEPT9 KD cells, the mid-
body either persisted until the next division (Fig. 3, C and D) or 
had not broken 40 h after the onset of cytokinesis. In some 
cases, the midbody broke when both daughter cells reentered 
mitosis, whereas in other cases it persisted even after a second 
round of division. The remaining 10% of SEPT9 KD cells   
exhibited one of two phenotypes: either the midbody regressed 
after failing to abscise, giving rise to a multinucleated cell (thus 
accounting for our fixed-cell results), or one or both daughter 
cells  underwent  apoptosis  after  being  unable  to  complete   
Figure 3.  SEPT9 mediates midbody abscission. (A–C) HeLa cells were transfected with siRNA, and randomly selected cells were followed through divi-
sion by time-lapse microscopy. The time (in hours:minutes) since the beginning of DNA segregation is shown. Black arrows point to intact midbodies, 
whereas white arrows denote abscission. Bars, 32 µm. (A) Division of HeLa cells after treatment with control siRNA. (B) SEPT11 KD causes defects early   
in cytokinesis. (C) SEPT9 KD causes defects in midbody abscission. See Videos 1–5 for complete movies. (D and E) Quantification of the effect of SEPT9 KD 
on midbody abscission in HeLa (D) and ARPE-19 cells (E). The time from DNA segregation to midbody abscission was determined, and the cumulative 
percentage of cells that were abscised is plotted as a function of time. For D, n = 45 cells for control KD and n = 30 cells for SEPT9 KD; for E, n = 34 cells 
for control KD and n = 25 cells for SEPT9 KD.745 SEPT9 mediates midbody abscission • Estey et al.
of siRNA-resistant SEPT9_i3 significantly reduced these defects 
(Fig. 4, C and E; compare SEPT9 KD in the parent cell line to 
SEPT9 KD in the SEPT9_i3 cell line). This not only demonstrates 
the specificity of our SEPT9 siRNA, but also argues that SEPT9_i3 
is sufficient to drive cytokinesis in the absence of the other SEPT9 
isoforms. Similar results were obtained with SEPT9_i1 (unpub-
lished data), which only differs from SEPT9_i3 at the extreme   
N terminus (Fig. S2 A). SEPT9_i2 was not tested because it is not 
expressed in HeLa cells (Burrows et al., 2003).
SEPT9_i4 lacks the SEPT9 N-terminal region (Fig. S2 A),   
and has been shown to be overexpressed in many tumors 
(Burrows et al., 2003; Scott et al., 2006). To assess whether 
SEPT9_i4 is also sufficient to drive cytokinesis in the absence 
of other SEPT9 isoforms, we generated a stable cell line that 
inducibly expresses siRNA-resistant SEPT9_i4 (Fig. 4 B). The 
basal expression of SEPT9_i4 in this cell line is similar to 
the expression level of endogenous SEPT9_i1–_i3 (Fig. 4 D). 
Interestingly, this level of SEPT9_i4 expression in itself induced 
persistent midbodies and multinucleation (Figs. 4 E and S2 B; 
compare control KD in the parent cell line to control KD in 
the SEPT9_i4 cell line). These defects were not suppressed 
by depleting endogenous SEPT9 (Figs. 4 E and S2B), which 
suggests that they are not simply the result of increased total 
SEPT9 levels. Further, depletion of endogenous SEPT9 in the 
SEPT9_i4 cell line did not cause an increase in cytokinesis   
results suggest that septins contribute distinct functions at dif-
ferent stages of cell division: SEPT9 is important for mediating 
midbody abscission at the terminal stage of cytokinesis, whereas 
SEPT2 and SEPT11 have roles earlier in cytokinesis. It remains 
unclear whether other septins are also involved in abscission, as 
such a role may be obscured by the early cytokinesis defects that 
occur upon their depletion.
Given the unique phenotype observed upon specific deple-
tion of SEPT9, we decided to focus our attention on the role of 
SEPT9 during cell division. Because of complex alternative splic-
ing, there are five N-terminal variants of SEPT9 (Fig. S2 A). These 
are referred to as isoforms 1–5 (_i1 to _i5; Hall et al., 2008a), 
and HeLa cells express all isoforms except _i2 (Burrows et al., 
2003). Because our SEPT9 siRNA targets all isoforms, we as-
sessed whether individual isoforms are capable of rescuing the 
cytokinetic defect observed upon SEPT9 depletion. To this end, 
we  generated  a  stable  cell  line  that  expresses  siRNA-resistant 
SEPT9_i3 under the control of an inducible promoter (Fig. 4 A). 
In the absence of induction, this cell line exhibits low levels of 
leaky expression comparable to endogenous SEPT9 levels. First, 
we verified that SEPT9 KD in the parent cell line, from which the 
SEPT9_i3 stable line was derived, caused the expected cytokinetic 
defects (persistent midbodies and multinucleation resulting from 
abscission failure, which we refer to collectively as “unresolved 
cytokinesis”; Fig. 4, C and E). In contrast, the basal expression 
Figure  4.  The  SEPT9  isoforms  are  not  all 
functionally equivalent. (A and B) Stable cell 
lines  inducibly  expressing  siRNA-resistant 
Flag-SEPT9_i3 (A) or Flag-SEPT9_i4 (B) were 
treated  with  increasing  amounts  of  doxycy-
cline, and expression was assayed by Western 
blotting. (C) The parent and Flag-SEPT9_i3 cell 
lines were treated with control or SEPT9 siRNA 
in the absence of doxycycline, and SEPT9   
levels were assayed by Western blotting. Note 
that SEPT9_i4 disappears upon treatment with 
SEPT9 siRNA, demonstrating efficient KD. Also 
note  the  higher  SEPT9  (_i1-3)  levels  in  the 
Flag-SEPT9_i3 stable line upon SEPT9 deple-
tion,  when  compared  with  the  parent  line.   
(D)  The  parent  and  Flag-SEPT9_i4  cell  lines 
were treated as in C. Numbers to the right of 
the blots represent molecular mass standards 
in kilodaltons. (E) The parent, Flag-SEPT9_i3, 
and Flag-SEPT9_i4 cell lines were treated with 
control or SEPT9 siRNA and assayed for de-
fects  in  cytokinesis  by  immunofluorescence 
microscopy.  Unresolved  cytokinesis  refers  to 
cells exhibiting midbody attachment or multi-
nucleation. Data are represented as mean ± 
SEM (error bars; n ≥ 300 cells from three or 
more independent experiments). *, P < 0.05; 
**, P < 0.005.JCB • VOLUME 191 • NUMBER 4 • 2010   746
et al., 2003); and Sec8, a component of the exocyst complex 
that mediates vesicle tethering at the midbody (Gromley et al., 
2005). SEPT9 KD had no effect on the midbody localization 
of  other  septins,  Cep55,  MAP4,  Plk1,  ROCKII,  or VAMP8 
(Fig. 5 A and Fig. S3). In contrast, depletion of SEPT9 re-
sulted in a drastic loss of the exocyst component Sec8 at the 
midbody (Fig. 5). In control KD cells, Sec8 was enriched at 
68% of midbodies; however, only 25% of SEPT9 KD cells ex-
hibited Sec8 enrichment at the midbody (Fig. 5, A–C). Quan-
tification of Sec8 fluorescence at the midbody verified these 
observations (Fig. 5 D). Previous work suggests that exocyst-
dependent tethering of vesicles at the midbody facilitates their 
fusion with the plasma membrane and with each other, thus 
contributing  to  abscission  (Gromley  et  al.,  2005).  Depletion 
of exocyst subunits results in abscission defects remarkably 
similar to those observed upon SEPT9 depletion (Gromley et al.,   
2005). SEPT9 is not important for the localization of most of 
the midbody proteins tested, but plays an important role in me-
diating  exocyst  complex  localization  to  the  midbody,  where 
it  facilitates  vesicle  fusion  that  is  important  for  abscission.   
Interestingly, SEPT9 and Sec8 did not colocalize at the mid-
body, but were found directly adjacent to each other (Fig. 5 E). 
Similar results have been observed in yeast, where septins act to 
defects, which indicates that SEPT9_i4 is acting in a dominant-
negative fashion. In contrast, inducing SEPT9_i3 expression up 
to 330% of total endogenous SEPT9 did not cause cytokinetic 
defects (unpublished data). SEPT9_i5 was not tested, as it is not 
recognized by our SEPT9 antibody. Our data point to an im-
portant role for the N-terminal region of SEPT9 in cytokinesis, 
which will be the subject of future study. Intriguingly, this region 
contains several putative phosphorylation sites, which could be 
important for SEPT9 function. These results suggest that even in-
dividual isoforms of a given septin can have diverse functions.
We next wanted to elucidate the molecular mechanism 
by which SEPT9 mediates abscission. We hypothesized that 
SEPT9 may help localize specific factors that are important for 
abscission at the midbody. To address this, we examined the 
localization of several midbody components upon SEPT9 de-
pletion. These included: SEPT2, SEPT7, and SEPT11; Cep55, a   
microtubule-bundling protein important for midbody integrity 
(Zhao et al., 2006); MAP4, a microtubule-stabilizing protein 
that associates with some septins (Kremer et al., 2005); Plk1, 
a regulator of cytokinesis (Petronczki et al., 2007); ROCKII, a   
kinase important for the completion of cytokinesis (Lowery   
et al., 2007); VAMP8, a SNARE protein that is thought to medi-
ate vesicle fusion at the midbody (Gromley et al., 2005; Low 
Figure 5.  SEPT9 mediates exocyst complex localization to the midbody. (A) Quantification of the effect of SEPT9 KD on the localization of midbody com-
ponents. The percentage of cells exhibiting enrichment of the protein of interest at the midbody was determined by immunofluorescence microscopy after 
control or SEPT9 KD. Data are represented as mean ± SEM (error bars; n ≥ 300 cells from three independent experiments). Asterisks indicate differences 
between control and SEPT9 KD cells; **, P < 0.001. (B and C) Representative example of the localization of the exocyst component Sec8 in cytokinetic 
cells upon control (B) or SEPT9 KD (C). Arrows point to the midbody. (D) Sec8 fluorescence at the midbody was quantified using ImageJ upon control or 
SEPT9 KD; **, P < 0.0001. (E) Double staining of SEPT9 and Sec8 in cytokinetic cells. Bars, 17 µm.747 SEPT9 mediates midbody abscission • Estey et al.
Western blotting
Western blotting was performed according to standard procedures using 
the following primary antibodies: SEPT9 (Surka et al., 2002), SEPT11 
(Huang et al., 2008), SEPT2 (Xie et al., 1999), SEPT6 (Huang et al., 
2008), SEPT7 (a gift from B. Zieger, University Hospital Freiberg, Freiberg, 
Germany), GAPDH (Millipore), Flag (Sigma-Aldrich), and CyclinB (Santa 
Cruz Biotechnology, Inc.).
siRNA treatment
siRNA for SEPT2 (5-GAATATTGTGCCTGTCATTG-3), SEPT6 (5-CCTGAA-
GTCTCTGGACCTAGT-3),  SEPT7  (5-TATATGCTGCACTGAATGGAA-3), 
SEPT9 (5-GCACGATATTGAGGAGAAA-3), SEPT11 (5-CAAGAGGA-
ATTGAAGATTAAA-3), and control siRNA (5-GCAGCGACCATGAG-
TATCA-3) were obtained from Thermo Fisher Scientific. Cells grown to 
60–80% confluence in 6-well plates were transfected with 120–240 pmol 
of double-stranded siRNA using Lipofectamine 2000 (Invitrogen). KD was 
achieved after 56–72 h. For siRNA treatment of stable cells lines, anti-
biotics were removed before transfection.
Immunofluorescence microscopy
Immunofluorescence microscopy was performed as described previously 
(Di Ciano-Oliveira et al., 2005) for analysis of cytokinetic defects (Figs. 2  
and  4).  Any  cells  connected  via  a  microtubule  bridge,  as  judged  by   
-tubulin staining (Sigma-Aldrich), were counted as being connected by a 
midbody. Any cell having more than one nucleus, as judged by Hoescht 
staining, was counted as being multinucleated. For analysis of the localiza-
tion of septins and midbody components (Figs. 1, 5, S1 C–E, and S3), 
cells were fixed for 5 min at 37°C with 2% paraformaldehyde in PBS,   
inactivated for 15 min at 37°C with 25 mM glycine and 25 mM ammo-
nium chloride in PBS, permeabilized for 15 min at room temperature with 
0.2% Triton X-100 in PBS, and blocked for 1 h in PBS with 0.1% saponin,   
1% horse serum, and 2% BSA. Cells were then incubated with the fol-
lowing primary antibodies: Sec8 (Abcam), Map4 (BD), Plk1 (Invitrogen), 
SEPT2 (Xie et al., 1999), SEPT7 (Santa Cruz Biotechnology, Inc.), SEPT9 
(Surka et al., 2002), SEPT11 (Huang et al., 2008), VAMP8 (a gift from 
T. Weimbs, University of California, Santa Barbara, Goleta, CA), and 
-tubulin (Sigma-Aldrich) or /-tubulin (Cell Signaling Technology). For 
Cep55, cells were transfected with GFP-Cep55 (a gift from K. Kutsche, 
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany) 2 d after 
treatment with control or SEPT9 siRNA. For ROCKII, cells were fixed with 
methanol, blocked in PBS with 10% FBS, and incubated with ROCKII anti-
body (Millipore). Cells were imaged using an inverted fluorescence micro-
scope (DMIRE2; Leica) equipped with a back-thinned EM charge-coupled 
device camera (Hamamatsu) and spinning disk confocal scan head. The 
unit was equipped with four separate diode-pumped solid-state laser lines 
(405 nm, 491 nm, 561 nm, and 638 nm; Spectral Applied Research),   
a motorized xy stage (ASI), an Improvision Piezo Focus Drive (PerkinElmer), 
and a 1.5× magnification lens (Spectral Applied Research). The equipment 
was driven by Volocity acquisition software, and powered by a Power 
Mac G5 (Apple).
Time-lapse microscopy
HeLa and ARPE-19 cells treated with the indicated siRNA were imaged in 
HPMI (RPMI powder [Invitrogen] supplemented with 15 mM sodium chlo-
ride and 20 mM Hepes, pH 7.4) at 37°C on an inverted microscope 
(TE2000; Nikon) adapted with a Solent environmental chamber. A Nikon 
Plan-Fluor 40×/0.6 NA objective was used in combination with a charge-
coupled device camera (Orca AG; Hamamatsu). The Improvision Volocity 
4.2 software suite was used for image acquisition, analysis, and manipula-
tion. The time from the beginning of chromosome segregation to midbody 
abscission was determined for each cell that started division within the first 
24 h of imaging. Cells that were multinucleated before division were ex-
cluded from analysis.
Generation and characterization of stable cell lines
Stable cell lines were generated using the Retro-X Tet-On Advanced Induc-
ible Expression System (Takara Bio Inc.). pRetroX-Tet-On-Advanced was 
transfected into FLYRD18 packaging cells (a gift from C. Tailor and S. Duffy, 
Hospital for Sick Children, Toronto, Canada) using the calcium phosphate 
method, and the media was changed 24 h later. After an additional 24 h,   
the virus-containing media was filtered (using a 0.2 µm HT Tuffryn filter; Pall), 
and polybrene (Sigma-Aldrich) was added to 8 µg/ml. The virus-containing 
media was then added to wild-type HeLa cells, and the media was sub-
sequently changed 4–6 h after infection. 2 d later, G418 was added to a 
final concentration of 500 µg/ml. Individual colonies were expanded and 
compartmentalize the exocyst at the site of cleavage (Dobbelaere 
and Barral, 2004). Although more work is required to elucidate 
how SEPT9 regulates exocyst localization, this study has pro-
vided significant insight into the molecular function of SEPT9 
during cell division.
We have demonstrated that specific depletion of SEPT9 in 
HeLa, HEK293, and ARPE-19 cells causes defects in midbody 
abscission. Although deletion of the Sept9 gene in mice is em-
bryonic lethal, embryos survive for 10 d before expiring, arguing 
that successful cell division can occur in the absence of SEPT9 
(Kinoshita, 2008). A possible explanation for this apparent dis-
crepancy is that abscission is not an absolute requirement for 
subsequent rounds of cell division. Consistent with this, SEPT9 
KD or expression of SEPT9_i4 resulted in some cells that were 
connected by persistent midbodies to multiple other cells. Similar 
results have been observed upon depletion of exocyst subunits 
(Gromley et al., 2005). In fact, Sec8 knockout embryos display 
no obvious phenotype up to embryonic day 6.5 (Friedrich et al.,   
1997). Further, during embryonic development, blastomeres   
often remain joined by intercellular bridges for several rounds 
of division (Goodall and Johnson, 1984; Eggert et al., 2006).   
Finally, the SEPT9 KD phenotype is incompletely penetrant so 
that some cells still do eventually divide normally, whereas   
others apparently achieve midbody breakage by mechanical 
strain caused by the subsequent division of the daughter cells. 
These observations could also contribute to the survival of SEPT9 
knockout embryos.
A significant body of work has linked alterations in SEPT9 
expression to cancer (Scott et al., 2005). Some of these instances 
involve a loss of SEPT9 function (Osaka et al., 1999; Russell   
et al., 2000; Yamamoto et al., 2002), whereas others involve SEPT9 
overexpression, either through amplification of the SEPT9 gene   
(Montagna et al., 2003) or increased expression of SEPT9_i4   
(Burrows et al., 2003; Scott et al., 2006) or SEPT9_i1 (Scott et al., 
2006; Gonzalez et al., 2007). The results presented here suggest 
that loss of SEPT9 function impairs the completion of cell division. 
This may result in genomic instability, ultimately contributing to 
cancer (Fujiwara et al., 2005). Increased expression of SEPT9_i4 
could have similar consequences, as we have demonstrated that 
modest increases in SEPT9_i4 levels cause defects in cytokinesis.
By specifically depleting SEPT9, we were able to eluci-
date the fact that this protein plays an important role in midbody 
abscission, a phenotype that is masked by simultaneous deple-
tion of other septins. Therefore, although depletion of all septin 
family members provides a good starting point for probing 
septin function, it will be important to analyze the role of indi-
vidual septins in septin-dependent processes. Our work further 
suggests that a complete understanding of septin function will 
also require careful consideration of the function of individual 
septin isoforms.
Materials and methods
Cell culture
HeLa, HEK293, and ARPE-19 cells were obtained from the American Type 
Culture Collection. HeLa and HEK293 cells were cultured as described 
previously (Surka et al., 2002), and ARPE-19 cells were grown in DME/F-12 
(Lonza) with 10% FBS.JCB • VOLUME 191 • NUMBER 4 • 2010   748
cells upon depletion of SEPT2 and SEPT11, respectively. Videos 4 and 5   
show the division of a HeLa cell upon depletion of SEPT9. Video 4 shows 
that cleavage furrow contraction is not affected by SEPT9 depletion, 
whereas Video 5 demonstrates that SEPT9 depletion impairs midbody 
abscission. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201006031/DC1.
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